TAK-875, an Orally Available G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1 Agonist, Enhances Glucose-Dependent Insulin Secretion and Improves Both Postprandial and Fasting Hyperglycemia in Type 2 Diabetic Rats

Yoshiyuki Tsujihata; Ryo Ito; Masami Suzuki; Ayako Harada; Nobuyuki Negoro; Tsuneo Yasuma; Yu Momose; Koji Takeuchi

doi:10.1124/jpet.111.183772

Research ArticleEndocrine and Diabetes

TAK-875, an Orally Available G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1 Agonist, Enhances Glucose-Dependent Insulin Secretion and Improves Both Postprandial and Fasting Hyperglycemia in Type 2 Diabetic Rats

Yoshiyuki Tsujihata, Ryo Ito, Masami Suzuki, Ayako Harada, Nobuyuki Negoro, Tsuneo Yasuma, Yu Momose and Koji Takeuchi

Journal of Pharmacology and Experimental Therapeutics October 2011, 339 (1) 228-237; DOI: https://doi.org/10.1124/jpet.111.183772

Yoshiyuki Tsujihata

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ryo Ito

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Masami Suzuki

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ayako Harada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nobuyuki Negoro

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tsuneo Yasuma

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yu Momose

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Koji Takeuchi

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
eLetters
PDF + SI
PDF

Submit a Response to This Article

Compose eLetter

Title *

Contents

More information about text formats

Plain text

No HTML tags allowed.
Web page addresses and e-mail addresses turn into links automatically.
Lines and paragraphs break automatically.

Author Information

Contributors
First Name and Middle Initial * First or given name, e.g. 'Peter'. Last Name * Your last, or family, name, e.g. 'MacMoody'. Email Address * Your email address, e.g. higgs-boson@gmail.com Occupation * Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Affiliation * Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.

Statement of Competing Interests

Competing interests? *

Yes

Please describe the competing interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.

PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics

Vol. 339, Issue 1

1 Oct 2011

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Back Matter (PDF)
Editorial Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following TAK-875, an Orally Available G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1 Agonist, Enhances Glucose-Dependent Insulin Secretion and Improves Both Postprandial and Fasting Hyperglycemia in Type 2 Diabetic Rats

Message Subject (Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics

Message Body (Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Research ArticleEndocrine and Diabetes